There were slight increases in certain digestive enzymes, like amylase and lipase, but only one case of serious pancreatitis
Comparing the two is like comparing a candle to a floodlight
"So nothing unexpected that we saw in safety, which actually gives us a lot of confidence tomove the program forward into phase two," Chakravarthy said, noting that Roche plans to start mid-stage studies in 2025
Discover how Niagen Biosciences patented NR safely and efficiently boosts cellular NAD+ levels
How Semaglutide (Ozempic/Wegovy) Regulates Hunger Signals and Satiety Semaglutide (the active ingredient in Ozempic and Wegovy) is a GLP-1 receptor agonist
Michigan, Rhode Island, and Wisconsin are planning or considering restrictions, according to KFFs most recent survey